RxDoctor Payments Data

Joseph Deveau, MD

Family Medicine · Fayetteville, GANPI 1962552257

Payments from drug & device makers

$644in general payments, 2019–2025

Across 32 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$75
  • Boehringer Ingelheim$72
  • GSK$53
  • Viiv Healthcare Company$52
  • Corcept Therapeutics$43
  • Johnson & Johnson$40
  • plus $308 from 14 others

What the payments were for

  • Food & beverage$644100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$644 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$158,176
Medicare patients
413
Services billed
1,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin139$195,770
OzempicSemaglutide92$99,874
MounjaroTirzepatide87$99,048
RybelsusSemaglutide31$41,977
JanuviaSitagliptin Phosphate34$41,430
TrulicityDulaglutide29$40,522
XareltoRivaroxaban29$26,987
ProliaDenosumab13$21,730
FarxigaDapagliflozin Propanediol21$19,028
EliquisApixaban23$15,992
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$14,765
Synjardy XrEmpagliflozin/Metformin Hcl23$13,881
Stiolto RespimatTiotropium Br/Olodaterol Hcl19$11,850
LinzessLinaclotide15$8,872
Levemir FlexpenInsulin Detemir22$5,428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Stiolto Respimat$72$221,500181 claims
Novo NordiskOzempic, Rybelsus$75$141,852123 claims
Lilly USA, LLCMounjaro, Trulicity$18$139,570116 claims
MerckJanuvia$24$41,43034 claims
Johnson & JohnsonXarelto$40$26,98729 claims
AstraZenecaFarxiga, Symbicort$20$21,79632 claims
AmgenProlia$18$21,73013 claims
PfizerEliquis$37$15,99223 claims
GSKTrelegy Ellipta$53$14,76521 claims
AbbVieLinzess, Synthroid$24$10,64937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →